Cargando…

PS247. High relapse rate after efficacious ultra-long term treatment of panic disorder with clonazepam or paroxetine

Detalles Bibliográficos
Autores principales:	Nardi, Antonio, Amrein, Roman, Cardoso, Adriana, Dias, Gisele, Freire, Rafael, Machado, Sergio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616842/ http://dx.doi.org/10.1093/ijnp/pyw043.247

Ejemplares similares

PS245. Outcome of naturalistic pharmacological treatment in panic disorder patients with the respiratory subtype
por: Freire, Rafael C, et al.
Publicado: (2016)

Efficacy of atropine combined with paroxetine in vagus nerve excitatory panic disorder
por: Du, Na, et al.
Publicado: (2015)

Three year naturalistic outcome study of panic disorder patients treated with paroxetine
por: Dannon, Pinhas N, et al.
Publicado: (2004)

Possible cross-sensitivity between sertraline and paroxetine in a panic disorder patient
por: Khairkar, Praveen H., et al.
Publicado: (2010)

Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder
por: Aoki, Akiko, et al.
Publicado: (2014)

The Implications of the Diving Response in Reducing Panic Symptoms
por: Kyriakoulis, Peter, et al.
Publicado: (2021)

Pancytopenia associated with clonazepam
por: Bautista-Quach, Marnelli A, et al.
Publicado: (2010)

Early Improvement and Marriage Are Determinants of the 12-Month Treatment Outcome of Paroxetine in Outpatients with Panic Disorder
por: Watanabe, Takashi, et al.
Publicado: (2017)

Pulsatile tinnitus: treatment with clonazepam and propranolol
por: Albertino, Sergio, et al.
Publicado: (2015)

“Nomophobia”: Impact of Cell Phone Use Interfering with Symptoms and Emotions of Individuals with Panic Disorder Compared with a Control Group
por: King, Anna Lucia Spear, et al.
Publicado: (2014)

Panic Disorder and Chronic Caffeine Use: A Case-control Study
por: Santos, Veruska Andrea, et al.
Publicado: (2019)

Panic disorder respiratory subtype: psychopathology and challenge tests – an update
por: Okuro, Renata T., et al.
Publicado: (2020)

A comparison of low-dose risperidone to paroxetine in the treatment of panic attacks: a randomized, single-blind study
por: Prosser, James M, et al.
Publicado: (2009)

COVID-19 and its psychological consequences: Beware of the respiratory subtype of panic disorder
por: Javelot, Hervé, et al.
Publicado: (2020)

Brain-Targeted Nasal Clonazepam Microspheres
por: Shaji, J., et al.
Publicado: (2009)

Clonazepam in the treatment of essential palatal tremors
por: Pandurangi, Aditya A., et al.
Publicado: (2012)

Clonazepam: Lack of efficacy: case report
Publicado: (2022)

Short-Term Efficacy and Tolerability of Paroxetine Versus Placebo for Panic Disorder: A Meta-Analysis of Randomized Controlled Trials
por: Zhang, Beilin, et al.
Publicado: (2020)

Enhanced interhemispheric resting-state functional connectivity of the visual network is an early treatment response of paroxetine in patients with panic disorder
por: Han, Yiding, et al.
Publicado: (2023)

Pharmacological and Neuromodulatory Treatments for Panic Disorder: Clinical Trials from 2010 to 2018
por: Zugliani, Morena M., et al.
Publicado: (2019)

The role of acid-sensitive ion channels in panic disorder: a systematic review of animal studies and meta-analysis of human studies
por: Quagliato, Laiana A., et al.
Publicado: (2018)

Paroxetine overdose
por: Gupta, Arun K., et al.
Publicado: (2005)

Design and Evaluation of Fast Dissolving Tablets of Clonazepam
por: Shirsand, S. B., et al.
Publicado: (2008)

Clonazepam/gabapentin: Lack of efficacy: case report
Publicado: (2022)

Virtual reality exposure therapy in panic disorder: a pilot study
por: Faria, Clara Gitahy Falcão, et al.
Publicado: (2021)

Antidepressant and Neuroprotective Effects of 3-Hydroxy Paroxetine, an Analog of Paroxetine in Rats
por: Hernández-Arrambide, Pedro Efraín, et al.
Publicado: (2022)

Treatment of Tardive Dyskinesia by tetrabenazine, clonazepam and vitamin E
por: Sharma, Himanshu
Publicado: (2009)

Formulation Design and Optimization of Fast Dissolving Clonazepam Tablets
por: Shirsand, S. B., et al.
Publicado: (2009)

Clonazepam Treatment of Pathologic Childhood Aerophagia with Psychological Stresses
por: Hwang, Jin-Bok, et al.
Publicado: (2007)

Clonazepam Treatment of Pathologic Aerophagia in Children with Mental Retardation
por: Lee, Ga-Hyun, et al.
Publicado: (2014)

Paroxetine-induced galactorrhea
por: Gulati, Prannay, et al.
Publicado: (2014)

Paroxetine-induced galactorrhea
por: Petrykiv, S., et al.
Publicado: (2022)

Comparison Between Tadalafil Plus Paroxetine and Paroxetine Alone in the Treatment of Premature Ejaculation
por: Moudi, Emadouddin, et al.
Publicado: (2016)

Changes in Cerebral Cortex and Limbic Brain Functions after Short-Term Paroxetine Treatment in Panic Disorder: An [(18)F]FDG-PET Pilot Study
por: Sim, Hyun-Bo, et al.
Publicado: (2010)

Clonazepam-induced lichenoid drug eruption: a case report
por: Yang, Hee Won, et al.
Publicado: (2021)

A Case Report of Excessive Use of Clozapine Combined With Clonazepam
por: Li, Wei, et al.
Publicado: (2022)

Comparison of Clonazepam and Tongue Protector in the Treatment of Burning Mouth Syndrome
por: Zborowski, Jacek, et al.
Publicado: (2022)

Clonazepam Loading Dose in Status Epilepticus: Is More Always Better?
por: D’Anto, Jennifer, et al.
Publicado: (2023)

Health Tract, No. 247: Filth and Purity
Publicado: (1866)

Paroxetine‐induced QTc prolongation
por: Otsuka, Yuji
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_r8qc21sh49kdeuriqv4or6sv7g